Today's financing environment has created a growing number of later stage medical device venture financing opportunities due to:

• The large number of medical device companies funded in the last 10 years
• Liquidity constraints created by the lack of a vibrant IPO market and fewer M&A exits
• The resulting need to finance companies longer with private equity
• A growing number of venture funds that are capital constrained or near the end of their terms

Our investment focus since early 2009 has been to provide financial alternatives to investors in late stage companies who:

• Do not have sufficient capital to support portfolio companies and risk having their preferred ownership being converted to common
• Wish to achieve liquidity on certain portfolio companies
• Need to reduce or eliminate future funding requirements
• Want to rebalance and reallocate fund reserves

Our investments are generally structured as a secondary direct transaction or as an economic interest in an investor's current ownership.  We have completed numerous transactions with venture capital funds, corporations and individuals.  We believe our investment process and the financial alternatives we provide are beneficial to all parties including the investor who is seeking a financial alternative, the portfolio company and management team who are seeking to complete a fully subscribed financing round and the co-investors who want to maintain an intact syndicate and/or add a new investor with deep medical device industry experience.

Because of the desire for confidentiality by the exisiting investors who seek the financial alternatives we have developed and offer, we do not disclose the names of companies in which we have made investments or have completed secondary transactions with one or more of their investors.